Related Experiment Video
Updated: Jan 20, 2026

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
Published on: January 10, 2025
Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules
Olivier Rager1,2, Piotr Radojewski1, Rebecca A Dumont1
1Nuclear Medicine Department, Geneva University Hospitals, Geneva, Switzerland.
Abstract:
The risk of malignancy in thyroid nodules with indeterminate cytological classification (Bethesda III-IV) ranges from 10% to 40%, and early delineation is essential as delays in diagnosis can be associated with increased mortality. Several radioisotope imaging techniques are available for discriminating benign from malignant cytologically indeterminate thyroid nodules, and for supporting clinical decision-making. These techniques include iodine-123, technetium-99m-pertechnetate, technetium-99m-methoxy-isobutyl-isonitrile (technetium-99m-MIBI), and fluorine-18-fluorodeoxyglucose (fluorine-18-FDG). This review discusses the currently available radioisotope imaging techniques for evaluation of thyroid nodules, including the mechanism of radiotracer uptake and the indications for their use.
Related Concept Videos
05:24Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
04:23A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
10:19Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
08:09Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
05:39Spontaneous Murine Model of Anaplastic Thyroid Cancer
Stereotypes, Prejudice, and Discrimination

